Company intelligence
Ferronova
To give everyone diagnosed with cancer their best chance to become cancer free
About Ferronova
Ferronova is an innovative medical device company, which has brought together a patented magnetic probe from the University of South Australia and iron magnetic nanoparticle technology from Victoria University of Wellington, to produce an advanced diagnostic system to improve the detection of cancer metastases. Ferronova has research collaborations with UniSA Future Industries Institute, the University of Sydney, and the University of New South Wales. Founded in 2016, Ferronova is backed by Uniseed, Artesian Ventures, ASX-listed investment group Powerhouse Ventures, PAN Ventures, UniSA Ventures and Wellington UniVentures. The South Australian government and Australian government have provided grant funding to develop the technology.
Verified activity
Signals from Ferronova
3 published signals
Research & Knowledge
Ferronova shared results from the SMF-3 magnetic sentinel lymph node mapping in upper gastrointestinal cancer trial exploring the accuracy of magnetically guided lymph node assessment against standard of care surgery and pathology.
Reported by Ferronova
Presence & Recognition
Ferronova is attending the 22nd World Congress of the International Society for Diseases of the Esophagus in Kyoto, Japan, on 16–18 September 2026.
Reported by Ferronova
Presence & Recognition
Ferronova participated in the MedTech Innovator Asia Pacific Accelerator Program and shared a 1-minute video explaining their technology and potential to improve cancer surgery.
Reported by Ferronova